Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Ingresos
575,824
584,507
596,569
552,147
521,051
456,414
Crecimiento de los Ingresos (YoY)
-2%
-2%
8%
6%
14%
7%
Costo de los ingresos
533,165
540,252
548,057
504,713
477,000
416,091
Utilidad bruta
42,659
44,255
48,511
47,434
44,050
40,323
Venta, General y Administración
26,144
26,697
27,082
23,790
22,101
20,328
Investigación y Desarrollo
--
--
--
--
--
--
Gastos de Operación
25,585
26,484
26,234
24,893
23,207
21,289
Otras Ingresos (Gastos) No Operativos
94
-165
-140
-131
-92
-286
Ingreso antes de impuestos
13,614
14,000
19,512
18,563
17,003
15,598
Gasto por Impuesto a la Renta
3,752
3,577
4,502
4,218
3,938
3,500
Ingreso Neto
6,811
7,049
9,053
8,525
7,758
7,187
Crecimiento de la Utilidad Neta
-21%
-22%
6%
10%
8%
15%
Acciones en Circulación (Diluidas)
3,120.53
3,120.65
3,120.65
3,120.65
3,120.65
3,111.29
Cambio de Acciones (YoY)
0%
0%
0%
0%
0%
5%
EPS (Diluido)
2.18
2.25
2.9
2.73
2.48
2.31
Crecimiento de EPS
-21%
-22%
6%
10%
8%
10%
Flujo de efectivo libre
17,094
9,577
14,837
18,546
7,052
9,067
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
7.4%
7.57%
8.13%
8.59%
8.45%
8.83%
Margen de operación
2.96%
3.04%
3.73%
4.08%
3.99%
4.17%
Margen de beneficio
1.18%
1.2%
1.51%
1.54%
1.48%
1.57%
Margen de flujo de caja libre
2.96%
1.63%
2.48%
3.35%
1.35%
1.98%
EBITDA
21,714
19,608
24,077
24,319
22,537
20,645
Margen de EBITDA
3.77%
3.35%
4.03%
4.4%
4.32%
4.52%
D&A para EBITDA
4,641
1,838
1,801
1,779
1,695
1,612
EBIT
17,073
17,770
22,276
22,540
20,842
19,033
Margen de EBIT
2.96%
3.04%
3.73%
4.08%
3.99%
4.17%
Tasa de Impuesto Efectiva
27.55%
25.55%
23.07%
22.72%
23.16%
22.43%
Estadísticas clave
Cierre Anterior
$13.5
Precio de apertura
$13.09
Rango del día
$13.09 - $13.69
Rango de 52 semanas
$10.72 - $14.13
Volumen
2.9K
Volumen promedio
29.3K
EPS (TTM)
1.57
Rendimiento de dividendos
--
Cap. de mercado
$3.6B
¿Qué es Sinopharm Group Co. Ltd.?
Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. The company is headquartered in Shanghai, Shanghai and currently employs 100,251 full-time employees. The company went IPO on 2009-09-23. The firm operates its business through four segments. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services to domestic and foreign pharmaceutical and health product manufacturers and other suppliers. The Device Distribution segment distributes medical devices to customers. The Pharmaceutical Retail Business segment owns a network of retail pharmacies that are directly operated or franchised. The Other Business segment is engaged in the manufacture and sale of pharmaceuticals, chemical reagents and laboratory supplies.